Product NewsDrug discovery > Clinical Development Immunovaccine Reports Promising Clinical Activity for Novel T Cell Activating Immunotherapy DPX-Survivac at ASCO 2014
Product NewsDrug discovery > Pre-Clinical Development Immunovaccine Reports Positive Results from Two Anthrax Studies
Industry NewsDrug discovery > Clinical Development Immunovaccine and NCIC Clinical Trials Group To Collaborate on Phase II Study of DPX-Survivac
